Thoracoscopic palliative treatment of malignant pleural effusions
- 2 May 2006
- journal article
- Published by Springer Science and Business Media LLC in Surgical Endoscopy
- Vol. 20 (6), 919-923
- https://doi.org/10.1007/s00464-005-0534-6
Abstract
The aim of this study was to analyze the results of pleurodesis for malignant pleural effusion performed by surgeons. A series of 273 patients with malignant pleural effusion underwent thoracoscopy with the aim of performing a palliative pleurodesis. There were 94 males (34.4%) and 175 females (64.1%), ranging in age from 15 to 94 years (mean age: 60.6 years). The effusion was on the right side in 136 patients (49.8%), on the left side in 110 (40.3%), and bilateral in 27 (9.9%). Thoracoscopy was performed under general anaesthesia in all patients. Pleural biopsy was performed in two thirds of the patients (70.7%). Pleurodesis was produced by instillation of 5g of sterile asbestos-free talc; the chest tube was left in place a minimum of 3 days. It was removed when fluid drainage was less than 200 ml/24 h. Patients were usually discharged the day after chest tube removal. There was no intraoperative mortality. Two patients (0.7%) had intraoperative complications; 17 (6.2%) underwent a bilateral pleurodesis, and 10 (3.7%) had a pericardiopleural window. In 32 patients (11.7%) no pleurodesis was done, either because the lung did not properly re-expand (5.2%), or because of suspected infection, e.g., false membranes (1.9%), or because of multiple adhesions (4.6%). Finally, only 241 patients (88.3%) had a talc poudrage at the time of thoracoscopy. Duration of postoperative pleural drainage ranged between 1 and 11 days (mean: 3.64 days). The postoperative hospital stay ranged from 2 to 21 days (mean: 7.1 days). Pleural empyema occurred in 4 patients (1.5%) and was lethal in one patient. The mean follow-up period was 8.39 (7.2 months, and 172 patients had regular follow up. In this group, there were 24 recurrences (14%), 12 of which were treated by repeat pleurodesis. The results were very good in 133 patients (77.3%), acceptable in 35 patients (20.3%), and there was a failure in 4 patients (2.4%). Results of surgical thoracoscopy for malignant pleural effusion are good, with low morbidity. However, in debilitated patients, bedside talc slurry may be preferable.Keywords
This publication has 19 references indexed in Scilit:
- Minimally Invasive Thoracic Surgery for Diagnostic Assessment and Palliative Treatment in Recurrent Neoplastic Pleural EffusionThe Thoracic and Cardiovascular Surgeon, 2004
- Pleurodesis in Patients with Malignant Pleural Effusions: Talc Slurry or Bleomycin? Results of a Prospective Randomized TrialWorld Journal of Surgery, 2004
- Pleurodesis Practice for Malignant Pleural Effusions in Five English-Speaking CountriesChest, 2003
- Efficacy and safety of single-trocar technique for minimally invasive surgery of the chest in the treatment of noncomplex pleural diseaseThe Journal of Thoracic and Cardiovascular Surgery, 2003
- BTS guidelines for the management of malignant pleural effusionsThorax, 2003
- BTS guidelines for the management of malignant pleural effusionsThorax, 2003
- Lung Damage in Experimental Pleurodesis Induced by Silver Nitrate or TalcChest, 2002
- Primary Treatment of Malignant Pleural Effusions: Video-Assisted Thoracoscopic Surgery Poudrage versus Tube ThoracostomyThe American Surgeon, 2002
- Management of malignant pleural effusionsEuropean Respiratory Journal, 2001
- Talc pleurodesis: Talc slurry versus thoracoscopic talc insufflation in a porcine modelThe Annals of Thoracic Surgery, 1996